EUVIMEDEUVIMED entdecken
Open Access

Endothelial Cell‐Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy

Shogo Tamura iD, Keitaro Akita iD, Michael A Fifer iD, Albree Tower-Rader iD, Mathew S Maurer iD, Yuichi J Shimada iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.042887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Shogo Tamura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences Columbia University New York NY USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Heart Failure, Endothelial Cells. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertrophic cardiomyopathy (HCM) often causes major adverse cardiovascular events (MACE) and worsening heart failure (HF). Endothelial cell (EC) dysfunction is known to be involved in the pathogenesis of HCM. However, the prognostic value of proteins related to EC function (EC‐related proteins) in HCM is unknown.

Methods

In this prospective cohort study of patients with HCM, we measured plasma levels of 90 EC‐related proteins upon enrollment. The primary outcome measure was MACE. The secondary outcome measure was worsening HF. We developed machine learning models based on EC‐related proteins to predict MACE or worsening HF using data from one institution (training set). We tested the predictive ability in independent samples from the other institution (test set) and performed time‐to‐event analyses.

Results

The study included 722 patients (n=458 in the training set and n=264 in the test set). Using our EC‐related protein‐based model, the area under the receiver‐operating‐characteristic curve to predict MACE was 0.71 (95% CI, 0.64–0.77) and that for worsening HF was 0.71 (95% CI, 0.63–0.79). When we divided the test set into low‐ and high‐risk groups according to the predicted probabilities derived from the training set, the high‐risk groups had significantly higher risks of developing MACE and worsening HF compared with the low‐risk groups (both P logrank

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicHeart FailureEndothelial CellsHumansMaleFemaleMiddle AgedProspective StudiesBiomarkersDisease ProgressionPrognosisRisk AssessmentAgedPredictive Value of TestsMachine LearningAdult

Stichwörter der Autor:innen

biomarkerendothelial cellhypertrophic cardiomyopathyprognosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Biological Sciences Columbia University New York NY USA.
  • Division of Cardiology, Department of Medicine Columbia University Irving Medical Center New York NY USA.
  • Cardiology Division, Department of Medicine Massachusetts General Hospital, Harvard Medical School Boston MA USA.

ORCID-Profile: Shogo Tamura, Keitaro Akita, Michael A Fifer, Albree Tower-Rader, Mathew S Maurer, Yuichi J Shimada

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS

Zitieren

APA

Tamura, S., Akita, K., Fifer, M. A., Tower-Rader, A., Maurer, M. S., & Shimada, Y. J. (2025). Endothelial Cell‐Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042887

Vancouver

Tamura S, Akita K, Fifer MA, Tower-Rader A, Maurer MS, Shimada YJ. Endothelial Cell‐Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042887

BibTeX
@article{Tamura2025,
  author = {Tamura, Shogo and Akita, Keitaro and Fifer, Michael A and Tower-Rader, Albree and Maurer, Mathew S and Shimada, Yuichi J},
  title = {Endothelial Cell‐Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.042887}
}
Kostenlos starten →